Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has issued an emergency use authorization for the monoclonal antibody sotrovimab to treat mild-to-moderate COVID-19 in patients at risk for progressing to severe disease, according to a press release. The emergency use authorization — now the third for a monoclonal antibody in the treatment of COVID-19 — is specifically for adults and children aged 12 years and older who weigh
Secretive hedge fund Elliott Management is understood to have phoned major GSK investors to discuss whether Emma Walmsley is the right choice to lead the FTSE 100 firm.
GSK, Vir’s COVID-19 mAb scores FDA emergency use approval Interim phase 3 trial results found sotrovimab reduced the risk of hospitalisation or death by 85% compared to placebo GlaxoSmithKline (GSK) and Vir Biotech’s COVID-19 monoclonal antibody (mAb) sotrovimab has been granted an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA). The EUA clears sotrovimab – previously known as VIR-7831 – for the treatment of mild-to-moderate COVID-19 in high-risk adults and certain paediatric patients who have a positive SARS-CoV-2 test. Interim trial results from a p...
Sotrovimab will be available for appropriate patients diagnosed with COVID-19 in the US in the coming weeks and discussions with global regulators regarding authorisations in additional countries continue to advance, said GSK
US regulator authorises GSK and Vir's sotrovimab for Covid treatment | Financial News